Spero Therapeutics, Inc. Share Price

Spero Therapeutics, Inc. Share Price

NASDAQ: SPRO | Micro Cap
$1.14
-$0.03 (-2.99%) Last updated on 29 Oct, 2026 | 20:36 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Spero Therapeutics, Inc. Stock Performance

Open
$1.16
Prev. Close
$1.17
Circuit Range
N/A
Day Range
$1.13 - $1.17
Year Range
$1.05 - $3.07
Volume
3,783
Average Traded
$1.14

Spero Therapeutics, Inc. Share Price Today

As of 29 October 2026, Spero Therapeutics, Inc.'s share price is $1.14. The stock opened at $1.16, compared to its previous close of $1.17. During today's trading session, Spero Therapeutics, Inc.'s share price traded between $1.13 and $1.17, with an average price of $1.15. Over the past 52 weeks, the stock has recorded a high of $3.07 and a low of $1.05. In terms of performance, Spero Therapeutics, Inc.'s share price has declined by 54.87% over the last six months and is down 53.29% on a year-on-year basis.

Spero Therapeutics, Inc. Share Price Chart

Line chart of the Spero Therapeutics, Inc. price trend over the selected period. The price fell overall, ranging from 1.13 to 1.17, ending at 1.14.
$1.13$1.17
L
Show Current Price
H

Spero Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$63.58M
PE Ratio (TTM)
8.99
Dividend Yield
0.00%
EPS (TTM)
$0.13
Revenue (TTM)
$66.80B
Return On Equity (TTM)
16.70%
Profit Margin
12.83%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-29.40%

Spero Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$5.44$41.30$0.26$0.00
Net Profit-$7.38$31.52-$7.20-$9.55
Net Profit Margin-135.66%76.32%-2769.23%N/A
Income ChangeN/A527.10%-122.84%-32.64%

Spero Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$53.51$103.78$47.98$66.80
Net Profit-$46.42$22.81-$68.57$8.57
Net Profit Margin-86.75%21.98%-142.91%12.83%
Income ChangeN/A149.14%-400.61%112.50%

About Spero Therapeutics, Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. It is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

Spero Therapeutics, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$1.20
$1.14
-5.81%
Sep 2026
$1.22
$1.21
-0.82%
Aug 2026
$1.18
$1.22
+2.97%
Jul 2026
$2.22
$1.18
-46.49%
Jun 2026
$2.81
$2.21
-21.81%
May 2026
$2.60
$2.82
+12.13%
Apr 2026
$2.41
$2.52
+7.48%
Mar 2026
$2.15
$2.34
+7.34%
Feb 2026
$2.16
$2.18
-0.23%
Jan 2026
$2.33
$2.19
-6.22%
Dec 2025
$2.31
$2.33
-2.92%
Nov 2025
$2.45
$2.40
-1.23%

SPRO Share Price FAQs